PVP21-3,81

Series:	*
Part Status:	Active

Due to market price fluctuations, if you need to purchase or consult the price. You can contact us or emial to us:   sales@allicdata.com

PVP21-3,81 Application Field and Working Principle

PVP21-3,81 is one of the most widely used and well-known products of the Plasmid Vector Systems (PVS). It is used in research and development projects related to gene editing, clinical diagnostics and therapeutic treatments. It is also used in industrial and medical applications.The product is a plasmid vector designed to generate a plasmid construct whose transgenes will insert within the correct site of the target DNA molecule. It allows for the sequence-specific insertion of transgenes into the target gene of interest. Its high precision eliminates the possibility of human error and contamination in the gene-editing process.PVP21-3,81 has a number of advantages over other plasmid vectors. Firstly, it is relatively easy to handle, requiring fewer steps than some of the more complex plasmid vectors. Secondly, its high degree of specificity makes it excellent for repetitive cloning projects that require high accuracy. Finally, because its transgene insertion occurs at specific sites in the target DNA molecule, it is less prone to genetic degradation over time.PVP21-3,81 is made from two replicons, a prokaryotic origin and an eukaryotic origin. The prokaryotic sequence provides the plasmid vector with a consensus restriction enzyme (RE) site that is compatible with a number of popular restriction enzymes. The eukaryotic sequence provides the scaffold onto which foreign DNA may be spliced. The reverse sequence also contains recognition sites that allow for the precise insertion of a transgene into the target DNA molecule.To ensure that the transgene insertion sites are precise, PVP21-3,81 utilizes a novel DNA polymerase system. This polymerase specifically recognizes and binds to the target DNA sequence, then checks the ends of each incoming nucleotide for correct orientation and sequence homology. Any misplaced nucleotides are rejected while correct nucleotides are promptly incorporated into the DNA chain.Finally, PVP21-3,81 encloses a sunscreen enzyme to protect the newly created plasmid from enzymes that may break it down over time. This method allows for the transgene to remain intact within the target DNA molecule for longer periods of time.In clinical and therapeutic applications, PVP21-3,81 enables researchers to target certain diseases with greater accuracy than ever before. By introducing transgenic proteins into target cells, researchers can create therapies that have the potential to cure many diseases. Furthermore, PVP21-3,81 can also be used to produce gene libraries for enhanced gene analysis.In conclusion, PVP21-3,81 is a powerful gene-editing tool that provides the precision and accuracy needed for medical and industrial applications. Its transgene insertion specificity and genome protection technologies offer unprecedented potential for the advancement of gene-based therapies. It is an essential part of advancing current gene engineering processes, and its flexibility and ease-of-use make it a great choice for researchers looking to make a difference in the world.

The specific data is subject to PDF, and the above content is for reference

Part Number	Manufacturer	Price	Quantity	Description